Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Nektar Therapeutics (NKTR)

-NasdaqGS
11.94 Up 0.25(2.14%) Feb 5, 4:00PM EST
|After Hours : 11.94 0.00 (0.00%) Feb 5, 4:49PM EST
Prev Close:11.69
Open:11.55
Bid:10.50 x 100
Ask:15.39 x 200
1y Target Est:18.20
Beta:0.842386
Earnings Date:Feb 22 - Feb 26 (Est.)
Day's Range:10.70 - 12.03
52wk Range:9.16 - 17.55
Volume:6,493,538
Avg Vol (3m):1,803,600
Market Cap:1.59B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 2.14%1.59B
GSKDown 0.54%98.64B
ENZNUp 1.68%21.11M
BMYDown 0.12%99.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.60
Quarterly EPS Est (Dec-15) :-0.39
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):2.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback